Nigel H Russell (Nigel Russell)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Top Venues

British journal of haematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jurjen Versluis, Marlen Metzner, Ariel Wang, Patrycja Gradowska, Abin Thomas, Niels Asger Jakobsen, Alison Kennedy, Rachel Moore, Emma Boertjes, Christian M Vonk, Francois G Kavelaars, Melissa Rijken, Amanda Gilkes, Claire Schwab, H Berna Beverloo, Markus Gabriel Manz, Otto Visser, Catharina H M J Van Elssen, Okke de Weerdt, Lidwine W Tick, Bart J Biemond, Marie-Christiane Vekemans, Sylvie D Freeman, Christine J Harrison, Jonathan Alistair Cook, Mike Dennis, Stephen Knapper, Ian Thomas, Charles F Craddock, Gert J Ossenkoppele, Bob Löwenberg, Nigel H Russell, Peter J M Valk, Paresh Vyas
Risk Stratification in Older Intensively Treated Patients With AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Mhairi Copland, Cono Ariti, Ian F Thomas, Laura Upton, Mia Sydenham, Priyanka Mehta, Shahid Islam, Lars Kjeldsen, Alan K Burnett, Robert K Hills, Nigel H Russell, Mike Dennis, null null
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial. British journal of haematology (2023)
Nigel H Russell, Robert K Hills, Lars Kjeldsen, Richard E Clark, Sahra Ali, Paul Cahalin, Ian F Thomas, Alan K Burnett
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial. British journal of haematology 198 (3) (2022)
Francis Jay Mussai, Carmela De Santo, Paul Cheng, Ian F Thomas, Cono Ariti, Laura Upton, Ugo Scarpa, Victoria Stavrou, Mia Sydenham, Alan K Burnett, Steven K Knapper, Priyanka Mehta, Mary Frances Frances McMullin, Mhairi Copland, Nigel H Russell, Mike Dennis
A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial. British journal of haematology (2022)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Ruth M de Tute, Anna Hockaday, Corinne Collett, John R Jones, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Alberto Rocci, John A Snowden, Matthew W Jenner, Gordon Cook, Nigel H Russell, Mark T Drayson, Walter Martin Gregory, Martin F Kaiser, Roger G Owen, Faith E Davies, Gareth J Morgan, null null
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLoS medicine 18 (1) (2021)
Richard Dilon, Robert K Hills, Alan K Burnett, Nigel H Russell
Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials. British journal of haematology (2021)
David C Linch, Robert K Hills, Alan K Burnett, Nigel H Russell, Rosemary E Gale
Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia. British journal of haematology (2021)
Thomas Coats, Daniel Bean, Aymeric Basset, Tamir Sirkis, Jonathan Brammeld, Sean Johnson, Ian Thomas, Amanda Gilkes, Kavita Raj, Mike Dennis, Steve Knapper, Priyanka Mehta, Asim Khwaja, Hannah Hunter, Sudhir Tauro, David Bowen, Gail Jones, Richard Dobson, Nigel H Russell, Richard Dilon
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia. British journal of haematology 196 (6) (2021)
Alan K Burnett, Nigel H Russell, Robert K Hills, Stephen Knapper, Sylvie D Freeman, Brian James Patrick Huntly, Richard E Clark, Ian F Thomas, Lars Kjeldsen, Mary Frances Frances McMullin, Mark Drummond, Jonathan Kell, Ruth Spearing
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2020)
Richard Dillon, Nicola Potter, Sylvie Freeman, Nigel H Russell
How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML). British journal of haematology 193 (2) (2020)